ATLASWisdomTree U.S. Multifactor Fund (USMF): outlook, holdings and fees
WisdomTree U.S. Multifactor Fund (USMF) is an exchange-traded fund and is managed by WisdomTree. The expense ratio is 0.28% and the yield is 1.26%. The ten largest holdings are 21% of the fund.
Fund data as of Oct 14, 2026 · Price Nov 2, 2026
ATLAS view on USMF
| Last price | $51.32 (-2.0%) |
|---|---|
| ATLAS chance of a higher price in 1 month | 56% |
| Likely 1-month range (50%) | $50.33 – $52.85 |
| Normal 1-day range (±1σ) | ±0.8% |
| Distribution yield | 1.26% |
ATLAS probabilities use the same calibrated model as every stock page. A fair value is shown for companies, not funds; the holdings below link to the fair value of each company.
USMF fund facts
| Issuer | WisdomTree |
|---|---|
| Theme | US large caps |
| Assets under management | $271M |
| Expense ratio | 0.28% |
| Number of holdings | 50 |
| Portfolio turnover | 98% |
| Inception | Jun 29, 2017 |
| Exchange | CBOE |
Under normal circumstances, at least 80% of the fund's total assets will be invested in constituent securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such constituent securities. The index is generally comprised of 200 U.S. companies with the highest composite scores based on two fundamental factors and two technical factors (momentum and TAPE, a proprietary machine learning model-based price and volume signal). The fund is non-diversified.
USMF top holdings
| Holding | Sector | Weight |
|---|---|---|
| Apple Inc. AAPL | Technology | 4.55% |
| Alphabet Inc Class A GOOGL | Communication Services | 4.16% |
| NVIDIA Corporation NVDA | Technology | 4.06% |
| Broadcom Inc AVGO | Technology | 1.59% |
| Eli Lilly and Company LLY | Healthcare | 1.36% |
| Expedia Group Inc. EXPE | Consumer Cyclical | 1.20% |
| Micron Technology Inc MU | Technology | 1.08% |
| Murphy USA Inc MUSA | Consumer Cyclical | 1.08% |
| eBay Inc EBAY | Consumer Cyclical | 1.09% |
| General Motors Company GM | Consumer Cyclical | 1.07% |
Holdings with an ATLAS page link to their probability range, fair value and earnings calendar.
USMF sector breakdown
| Sector | Weight |
|---|---|
| Technology | 35.0% |
| Healthcare | 14.8% |
| Consumer Cyclicals | 10.6% |
| Industrials | 8.8% |
| Financial Services | 8.5% |
| Communication Services | 8.0% |
| Consumer Defensive | 5.1% |
| Energy | 4.5% |
| Real Estate | 1.7% |
| Utilities | 1.6% |
| Basic Materials | 1.5% |
By region: North America 99.0%, Latin America 0.7%, United Kingdom 0.4%.
USMF returns and risk
| Year to date | +4.7% |
|---|---|
| 1 year | +3.3% |
| 3 years (annualised) | +13.5% |
| 5 years (annualised) | +7.8% |
| 10 years (annualised) | 0.0% |
| Volatility (3 years) | 11.5% |
| Sharpe ratio (3 years) | 0.68 |
Past returns do not guarantee future results.
USMF: frequently asked questions
What does USMF invest in?
WisdomTree U.S. Multifactor Fund invests in a portfolio of securities. Its largest holdings are Apple Inc. (4.6%), Alphabet Inc Class A (4.2%), NVIDIA Corporation (4.1%), Broadcom Inc (1.6%), Eli Lilly and Company (1.4%).
What is the USMF expense ratio?
0.28% a year: about $28.00 for every $10,000 invested.
What is the USMF dividend yield?
1.26%. ATLAS does not hold the exact distribution dates for ETFs.
Will USMF go up?
Nobody can know. The ATLAS model puts the chance of a higher price in one month at 56%, with a likely range (50%) of $50.33 to $52.85 from $51.32 today. It is a probability, not a prediction.
How has USMF performed?
Year to date +4.7%, one year +3.3%, three years +13.5% a year, five years +7.8% a year. Past returns do not guarantee future results.
Similar ETFs: US large caps
- Vanguard Total Stock Market ETF (VTI)
- Schwab U.S. Dividend Equity ETF (SCHD)
- iShares Core S&P Total U.S. Stock Market ETF (ITOT)
- Schwab U.S. Large-Cap ETF (SCHX)
- Schwab U.S. Large-Cap Growth ETF (SCHG)
- Vanguard Morningstar Large-Cap ETF (VV)
- Dimensional U.S. Core Equity 2 ETF (DFAC)
- iShares MSCI USA Quality Factor ETF (QUAL)
Educational information, not investment advice. Disclaimer